ACTIVE SURVEILLANCE IN LOW-RISK PROSTATE CANCER PATIENTS: A 5-YEAR SINGLE INSTITUTION EXPERIENCE

被引：0
|
作者：
Giganti, Maria Olga [1 ]
Rancati, Tiziana [1 ]
Nicolai, Nicola [2 ]
Villa, Sergio [3 ,4 ]
Donegani, Simona [1 ]
Magnani, Tiziana [1 ]
Bedini, Nice [3 ,4 ]
Salvioni, Roberto [2 ]
Valdagni, Riccardo [1 ]
机构：
[1] Fondazione IRCCS, Ist Nazl Tumori, Sci Directors Off, Milan, Italy
[2] Fondazione IRCCS, Ist Nazl Tumori, Dept Urol, Milan, Italy
[3] Fondazione IRCCS, Ist Nazl Tumori, Dept Radiotherapy, Milan, Italy
[4] Fondazione IRCCS, Ist Nazl Tumori, Multidisciplinary Clin Working Grp, Milan, Italy
来源：
ANTICANCER RESEARCH | 2010年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287
引用
收藏
页码：1540 / 1541
页数：2
相关论文
共 50 条
  • [31] A SYSTEMATIC APPROACH TO DISCUSSING ACTIVE SURVEILLANCE TO PATIENTS WITH LOW-RISK PROSTATE CANCER
    Ehdaie, Behfar
    Asset, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    JOURNAL OF UROLOGY, 2016, 195 (04): : E409 - E409
  • [32] Active surveillance can reduce overtreatment in patients with low-risk prostate cancer
    Thomsen, Frederik Birkaebk
    Roder, Martin Andreas
    Hvarness, Helle
    Iversen, Peter
    Brasso, Klaus
    DANISH MEDICAL JOURNAL, 2013, 60 (02):
  • [33] How useful is immunohistochemistry in patients on active surveillance for low-risk prostate cancer?
    Eldefrawy, A.
    Ransford, G.
    Pan, D.
    Umar, S.
    Jorda, M.
    Soloway, M. S.
    BJU INTERNATIONAL, 2013, 111 : 38 - 39
  • [34] Predicting progression in patients followed with active surveillance for low-risk prostate cancer
    Sternberg, Itay Aharon
    Yu, Changhong
    Paz, Gal Elimelech Keren
    Kim, Philip H.
    Bernstein, Melanie
    Lakin, Paul
    Kattan, Michael W.
    Ehdaie, Behdar
    Laudone, Vincent Paul
    Scardino, Peter T.
    Eastham, James Andrew
    Touijer, Karim A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [35] A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer
    Ehdaie, Behfar
    Assel, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    EUROPEAN UROLOGY, 2017, 71 (06) : 866 - 871
  • [36] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Badrinath R Konety
    Nature Clinical Practice Urology, 2008, 5 : 277 - 283
  • [37] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [38] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
  • [39] THE ERA OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IS HERE
    Sountoulides, Petros
    Obek, Can
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (02): : 49 - 51
  • [40] Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer
    Chiang, Andrew Szehsun
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345